Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
What we are developing could be used as something like maintenance therapy where you could get subcutaneous injections every 3 to 6 months. The market opportunity also resulted in a dramatic legal battle between Pfizer and Novo Nordisk last year, when the two companies fought over buying Metsera, a start-up developing weight-loss drugs
Plamboeck A, Veedfald S, Deacon C, Wettergren A, Svendsen L, Meisner S et al
Borgstrom L, Kagedal B (1990)
JAMA Intern Med 184(9):10561064 Zhang M, Lin C, Cai X, Jiao R, Bai S, Li Z et al (2025) One or two
120
US$ 26.84
US$ 20.48
US$ 29.45
US$ 20.20
